ArticleFrontiers in oncology2024

Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis.

Marcin Kubeczko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.